B. Metzler seel. Sohn & Co. Holding AG Acquires Shares of 9,140 Inspire Medical Systems, Inc. (NYSE:INSP)

B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 9,140 shares of the company's stock, valued at approximately $1,929,000.

Several other hedge funds and other institutional investors have also bought and sold shares of INSP. Bessemer Group Inc. raised its stake in Inspire Medical Systems by 1.2% in the 1st quarter. Bessemer Group Inc. now owns 8,475 shares of the company's stock worth $1,820,000 after purchasing an additional 100 shares in the last quarter. 1832 Asset Management L.P. acquired a new position in shares of Inspire Medical Systems in the 1st quarter valued at approximately $1,740,000. Lazard Asset Management LLC raised its position in shares of Inspire Medical Systems by 85.0% in the 1st quarter. Lazard Asset Management LLC now owns 63,196 shares of the company's stock valued at $13,573,000 after buying an additional 29,039 shares in the last quarter. Brown Capital Management LLC acquired a new position in shares of Inspire Medical Systems in the 1st quarter valued at approximately $16,839,000. Finally, Hood River Capital Management LLC raised its position in shares of Inspire Medical Systems by 21.0% in the 1st quarter. Hood River Capital Management LLC now owns 189,237 shares of the company's stock valued at $40,646,000 after buying an additional 32,796 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on INSP. Leerink Partners boosted their target price on shares of Inspire Medical Systems from $167.00 to $197.00 and gave the company a "market perform" rating in a research report on Tuesday, September 10th. Bank of America upgraded shares of Inspire Medical Systems from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $220.00 to $255.00 in a research report on Wednesday. Wells Fargo & Company upped their price objective on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the stock an "equal weight" rating in a research report on Tuesday, November 5th. Truist Financial reiterated a "buy" rating and set a $240.00 price objective (up from $217.00) on shares of Inspire Medical Systems in a research report on Monday, September 30th. Finally, Stifel Nicolaus reiterated a "hold" rating and set a $200.00 price objective (up from $170.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $233.58.

Inspire Medical Systems Stock Up 1.4 %

Inspire Medical Systems stock traded up $2.54 during mid-day trading on Friday, hitting $188.73. 471,836 shares of the stock were exchanged, compared to its average volume of 598,307. The stock has a market capitalization of $5.66 billion, a price-to-earnings ratio of 176.38 and a beta of 1.36. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40. The firm's fifty day simple moving average is $199.53 and its two-hundred day simple moving average is $175.81.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The business had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. During the same quarter in the previous year, the business earned ($0.29) earnings per share. Inspire Medical Systems's revenue for the quarter was up 32.6% on a year-over-year basis. As a group, analysts forecast that Inspire Medical Systems, Inc. will post 1.33 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Shawn Mccormick sold 800 shares of the stock in a transaction on Monday, September 9th. The shares were sold at an average price of $220.00, for a total transaction of $176,000.00. Following the transaction, the director now directly owns 23,140 shares of the company's stock, valued at $5,090,800. This represents a 3.34 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.10% of the stock is currently owned by corporate insiders.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.